Acyclovir blocks cytokine gene expression in trigeminal ganglia latently infected with herpes simplex virus type 1

Virology

Volumn 238, Issue 1, 1997, Pages 53-63

  Halford, William P ^a   Gebhardt, Bryan M ^a   Carr, Daniel J J ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA REPLICATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HERPES SIMPLEX VIRUS 1; LATENT PERIOD; LATENT VIRUS INFECTION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TRIGEMINUS GANGLION;

ANIMALIA; HERPES; HUMAN HERPESVIRUS 1;

EID: 0031564064     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8806     Document Type: Article

References (48)

1. Bailey, K.A., Drago, J., and Bartlett, P. F. (1994). Neuronal progenitors identified by their inability to express class I histocompatability antigens in response to interferon-γ. J. Neurosci. Res. 39, 166-177.
2. Bean, B., and Aeppli, D. (1985). Adverse effects of high-dose intravenous acyclovir in ambulatory patients with acute herpes zoster. J. Infect. Dis. 151, 362-365.
3. Becker, B. N., Fall, P., Hall, C., Milam, D., Leonard, J., Glick, A., and Schulman, G. (1993). Rapidly progressive acute renal failure due to acyclovir: case report and review of the literature. Am. J. Kidney Dis. 22, 611-615.
4. Bishop, S. A., and Hill, T. J. (1989). Herpes simplex virus infection and damage in the central nervous system: Immune response to myelin basic protein. J. Neurol. Sci. 91, 109-118.
5. Blatt, A. N., Laycock, K. A., Brady, R. H., Traynor, P., Krogstad, D. J., and Pepose, J. S. (1993). Prophylactic acyclovir effectively reduces herpes simplex virus type 1 reactivation after exposure of latently infected mice to ultraviolet B. Invest. Ophthalmol. Vis. Sci. 34, 3459-3465.
6. Blondeau, J. M., Aoki, F. Y., and Nagy, J. I. (1993). Immunohistological characterization of acute herpes simplex virus infection in lumbar dorsal root ganglia of the rat. J. Med. Microbiol. 38, 265-269.
7. Cantin, E. M., Hinton, D. R., Chen, J., and Openshaw, H. (1995). Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1. J. Virol. 69, 4898-4905.
8. De La Torre, J. C., Mallory, M., Brot, M., Gold, L., Koob, G., Oldstone, M. B. A., and Masliah, E. (1996). Viral persistence in neurons alters synaptic plasticity and cognitive functions without destruction of brain cells. Virology 220, 508-515.
9. Di Lazarro, C., Campadelli-Fiume, G., and Torri, M. R. (1995). Intermediate forms of glycoconjugates are present in the envelope of herpes simplex virions during their transport along the exocytic pathway. Virology 214, 619-623.
10. Dingwell, K. S., Doering, L. C., and Johnson, D. C. (1995). Glycoproteins E and I facilitate neuron-to-neuron spread of herpes simplex virus. J. Virol. 69, 7087-7098.
11. Elion, G. B. (1993). Acyclovir: Discovery, mechanism of action, and selectivity. J. Med. Virol. 41(Suppl. 1), 2-6.
12. Elion, G. B., Furman, P. A., Fyfe, J. A., de Miranda, P., Beauchamp, L., and Schaeffer, H. J. (1977). Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine. Proc. Natl. Acad. Sci. USA 74, 5716-5719.
13. Goldberg, L.H., Kaufman, R., Kurtiz, T. O., Conant, M. A., Eron, L.J., Batenhorst, R. L., and Boone, G. S. (1993). Long-term suppression of recurrent genital herpes with acyclovir. Arch. Dermatol. 129, 582-587.
14. Green, M. T., Courtney, R. J., and Dunkel, E. C. (1981). Detection of an immediate early herpes simplex virus type 1 polypeptide in trigeminal ganglia from latently infected animals. Infect. Immun. 34, 987-992.
15. Haefeli, W. E., Schoenenberger, R. A. Z., Weiss, P., and Ritz, R. F. (1993). Acyclovir-induced neurotoxicity: Concentration-side effect relationship in acyclovir overdose. Am. J. Med. 94, 212-215.
16. Halford, W. P., and Carr, D. J. J. (1995). Subversion of intracellular signal transduction by herpes simplex virus type 1. Adv. Neuroimmunol. 5, 327-334.
17. Halford, W. P., Gebhardt, B. M., and Carr, D. J. J. (1996a). Persistent cytokine expression in the trigeminal ganglion latently infected with herpes simplex virus type 1. J. Immunol. 157, 3542-3549.
18. Halford, W. P., Gebhardt, B. M., and Carr, D. J. J. (1996b). Mechanisms of herpes simplex virus type 1 reactivation. J. Virol. 70, 5051-5060.
19. Hill, J. M., Gebhardt, B. M., Wen, R., Bouterie, A. M., Thompson, H. W., O'Callaghan, R. J., Halford, W. P., and Kaufman, H. E. (1996a). Quantitation of HSV-1 DNA and LAT in rabbits trigeminal ganglia demonstrates a stable reservoir of viral nucleic acids during latency. J. Virol. 70, 3137-3141.
20. Hill, J. M., Halford, W. P., Wen, R., Engel, L. S., Green, L. C., and Gebhardt, B. M. (1996b). Quantitative analysis of polymerase chain reaction products by dot blot. Anal. Biochem. 235, 44-48.
21. Itoyama, Y., Sekizawa, T., Openshaw, H., Kogure, K., and Kuroiwa, Y. (1984). Immunocytochemical localization of herpes simplex virus antigen in the trigeminal ganglia of experimentally infected mice. J. Neurol. Sci. 66, 67-75.
22. Joly, E., Mucke, L., and Oldstone, M. B. A. (1991). Viral persistence in neurons explained by lack of major histocompatibility class I expression. Science 253, 1283-1285.
23. Kankova-Vancurova, M., Jlek, P., Fisterle, V., and Prochazkova, J. (1990). Effect of acyclovir on selected immune functions. Acta Virol. 36, 284-292.
24. Kaufman, H. E., Varnell, E. D., Cnetifanto-Fitzgerald, Y. M., DeClerq, E., and Kissling, G. E. (1983). Oral antiviral drugs in experimental herpes simplex keratitis. Antimicrob. Agents Chemother. 24, 888-891.
25. Kinghorn, G. R., Wooley, P. D., Thin, R. N. T., De Maubeuge, J., Foidart, J. M., and Engst, R. (1992). Acyclovir vs isoprinone (immunovir) for suppression of recurrent genital herpes simplex infection. Genitourin. Med. 68, 312-316.
26. Knotts, F. B., Cook, M. L., and Stevens, J.G. (1974). Pathogenesis of herpetic encephalitis in mice after ophthalmic inoculation. J. Infect. Dis. 130, 16-27.
27. Kosz-Knenchak, M., Jacobson, J., Coen, D. M., and Knipe, D. M. (1993). Evidence for a novel regulatory pathway for herpes simplex virus gene expression in the trigeminal ganglion neurons. J. Virol. 67, 5383-5393.
28. Kramer, M., and Coen, D. M. (1995). Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus. J. Virol. 69, 1389-1399.
29. Liu, T., Tang, Q., and Hendricks, R. L. (1996). Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J. Virol. 70, 264-271.
30. Mehta, A., Maggioncalda, J., Bagasra, O., Thikkavarapu, S., Saikumari, P., Valyi-Nagy, T., Fraser, N. W., and Block, T. M. (1995). In situ DNA PCR and RNA hybridization detection of herpes simplex virus sequences in trigeminal ganglia of latently infected mice. Virology 206, 633-640.
31. Mitchell, W. J., Gressens, P., Martin, J. R., and DeSanto, R. (1994). Herpes simplex virus type 1 DNA persistence, progressive disease, and transgenic immediate early gene promoter activity in chronic corneal infections in mice. J. Gen. Virol. 75, 1201-1210.
32. Neumann, H., Cavalie, A., Jenne, D. E., and Wekerle, H. (1995). Induction of MHC class I genes in neurons. Science 269, 549-552.
33. Nichol, P. F., Chang, J.Y., Johnson, E. M., Jr., and Olivo, P. D. (1996). Herpes simplex virus gene expression in neurons: Viral DNA synthesis is a critical regulatory element in the branch point between lytic and latent pathways. J. Virol. 70, 5476-5486.
34. Penford, M. E. T., Armati, P., and Cunningham, A. L. (1994). Axonal transport of herpes simplex virions to epidermal cells: Evidence for a specialized mode of virus transport and assembly. Proc. Natl. Acad. Sci. USA 91, 6529-6532.
35. Quinn, R. P., Wolberg, G., Medzihradsky, J., and Elion, G. B. (1982). Effect of acyclovir on various murine in vivo and in vitro immunologic assay systems. Am. J. Med. 73, 62-66.
36. Rall, G. F., Mucke, L., and Oldstone, M. B. A. (1995). Consequences of cytotoxic T lymphocyte interaction with major histocompatability complex class I-expressing neurons in vivo. J. Exp. Med. 182, 1201-1212.
37. Ramakrishnan, R., Levine, M., and Fink, D. J. (1994). PCR-based analysis of herpes simplex virus type 1 latency in the rat trigeminal ganglion established with a ribonucleotide reductase-deficient mutant. J. Virol. 68, 7083-7091.
38. Roizman, B. (1996). Herpes simplex viruses and their replication. In "Virology" (B. N. Fields, D. M. Knipe, and P. M. Howley, Eds.), 3rd ed., pp. 2221-2230. Lippincott-Raven, Philadelphia, PA.
39. Sciammas, R., Johnson, R. M., Sperling, A. I., Brady, W., Linsley, P. S., Spear, P. G., Fitch, F. W., and Bluestone, J. A. (1994). Unique antigen recognition by a herpesvirus-specific TCR-γδ cell. J. Immunol. 152, 5392-5397.
40. Shimeld, C., Hill, T., Blyth, B., and Easty, D. (1989). An improved model of recurrent herpetic eye disease in mice. Curr. Eye Res. 8, 1193-1205.
41. Shimeld, C., Whiteland, J. L., Nicholls, S. M., Grinfeld, E., Easty, D. L., Gao, H., and Hill, T. J. (1995). Immune cell infiltration and persistence in the mouse trigeminal ganglion after infection of the cornea with herpes simplex virus type 1. J. Neuroimmunol. 61, 7-16.
42. Sutton, D., and Boyd, M. R. (1993). Comparative activity of pencyclovir and acyclovir in mice infected intraperitoneally with herpes simplex virus type 1 SC16. Antimicrob. Agents Chemother. 37, 642-645.
43. Topp, K. S., Meade, L. B., and LeVail, J. H. (1994). Microtubule polarity in the peripheral processes of trigeminal ganglion cells: relevance for the retrograde transport of herpes simplex virus. J. Neurosci. 14, 318-325.
44. Torri, M. R., Di Lazorro, C., Pavan, A., Pereira, L., and Campadelli-Fiume, G. (1992). Herpes simplex virus envelopment and maturation studied by fracture label. J. Virol. 66, 554-561.
45. Tullo, A. B., Shimeld, C., Blyth, W. A., Hill, T. J., and Easty, D. I. (1982). Spread of virus and distribution of latent infection following ocular herpes simplex in the non-immune and immune mouse. J. Gen. Virol. 63, 95-101.
46. Willey, D. E., Trousdale, M. D., and Nesburn, A. B. (1984). Reactivation of murine latent HSV infection by epinephrine iontophoresis. Invest. Ophthal. Vis. Sci. 25, 945-950.
47. Winston, D. J., Wirin, D., Shaked, A., and Busuttil, R. W. (1995). Randomised comparison of ganciclovir and high dose acyclovir for long-term cytomegalovirus prophylaxis in liver transplant recipients. Lancet 346, 69-74.
48. Youle, M. S., Gazzard, B. G., Johnson, M. A., Cooper, D. A., Hoy, J. F., Busch, H., Ruf, B., Griffiths, P. D., Stephenson, S. L., Dancos, M., and Bell, A. R. (1994). Effects of high-dose oral acyclovir on herpesvirus disease and survival in patients with advanced HIV disease: A double blind, placebo-controlled study. AIDS 8, 641-649.